
Post-COVID-19 syndrome (PCS) presents enduring symptoms, notably fatigue and exertion intolerance, with uncertain long-term effects. A study at Berlin's Charité's Fatigue Centre tracked 106 PCS patients with moderate to severe fatigue at three time points post-infection. A subset met criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Findings reveal that PCS-ME/CFS patients experienced persistent symptoms for up to 20 months, while PCS patients showed gradual improvement. Fatigue and post-exertional malaise persisted in both groups, with stronger impact in PCS-ME/CFS. Inflammatory biomarkers decreased for both, but antinuclear antibodies did not. Lower hand grip strength at onset correlated with symptom persistence, especially in PCS-ME/CFS patients.
Like
Save
Share